| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥1298.0B | ¥1363.5B | -4.8% |
| Operating Income | ¥214.0B | ¥263.0B | -18.6% |
| Ordinary Income | ¥236.6B | ¥264.9B | -10.7% |
| Net Income | ¥174.9B | ¥199.4B | -12.3% |
| ROE | 11.7% | 14.6% | - |
FY2025 Q3 cumulative results showed revenue of 129.8B yen (YoY -4.8%), operating income of 21.4B yen (YoY -18.6%), ordinary income of 23.7B yen (YoY -10.7%), and net income of 17.5B yen (YoY -12.3%). The company experienced both revenue and profit declines, with operating margin declining to 16.5% from 19.3% in the prior year period. The profit decline outpaced the revenue decline due to deteriorating operating efficiency and higher SG&A costs relative to sales.
Revenue decreased 6.5B yen YoY to 129.8B yen, reflecting a 4.8% decline. Geographic analysis shows China revenue fell 2.3B yen to 33.6B yen and Other regions declined 8.8B yen to 39.2B yen, while Japan and Americas showed modest growth. Operating income fell 4.9B yen to 21.4B yen as gross profit margin remained stable at 48.0% but SG&A expenses remained elevated at 40.9B yen (ratio of 31.5%, up from 30.0% YoY), reducing operating margin by 2.8 percentage points. Non-operating items contributed a net gain of 2.3B yen, primarily from FX gains of 1.0B yen and equity method income of 0.5B yen, partially offsetting interest expense of 0.1B yen. Extraordinary items included gain on sale of securities of 1.0B yen, providing non-recurring support. Income tax expense of 7.2B yen resulted in an effective tax rate of 29.2%. Net income of 17.5B yen declined 12.3% YoY, with the smaller gap between ordinary and net income (2.4B yen difference) attributable to the securities sale gain offsetting normal tax burden. This represents a revenue down/profit down pattern, driven by volume decline in international markets and insufficient cost absorption.
Scientific and Measurement Instruments is the core business with revenue of 78.2B yen (60.3% of total) and operating income of 7.6B yen (operating margin 9.7%), down from 9.9B yen YoY. Industrial Equipment generated revenue of 40.6B yen (31.2% of total) with operating income of 17.8B yen (margin 44.0%), down from 20.4B yen YoY. Medical Equipment contributed revenue of 11.0B yen (8.5% of total) with operating income of 0.7B yen (margin 6.4%), relatively flat YoY at 0.8B yen. Industrial Equipment demonstrates the highest profitability with margin of 44.0%, significantly exceeding the other segments. The Scientific and Measurement Instruments segment experienced the largest absolute profit decline of 2.4B yen despite being the revenue leader, indicating pressure on this core business. Corporate costs not allocated to segments totaled 4.8B yen, primarily general administrative expenses.
[Profitability] ROE of 11.7% reflects net profit margin of 13.5%, asset turnover of 0.554x, and financial leverage of 1.57x. Operating margin of 16.5% declined 2.8 percentage points YoY from 19.3%, indicating operational efficiency deterioration. Gross margin remained stable at 48.0%. R&D intensity of 6.6% demonstrates continued technology investment. [Cash Quality] Cash and deposits of 38.0B yen provide 0.58x coverage of short-term liabilities. Working capital efficiency deteriorated significantly with receivables turnover of 123 days, inventory turnover of 100 days, and cash conversion cycle of 507 days, indicating substantial operational inefficiency. Work in process inventory of 57.2B yen represents 70.3% of total inventory, suggesting production bottlenecks. [Investment Efficiency] Asset turnover of 0.554x remains below optimal levels. Total assets increased to 234.1B yen from 222.5B yen, driven by property, plant and equipment growth of 10.0B yen (41.5% increase) and work in process buildup. Contract liabilities of 31.4B yen represent deferred revenue from customer advances. [Financial Health] Equity ratio of 63.9% reflects conservative capital structure. Current ratio of 258.7% and quick ratio of 230.4% indicate strong short-term liquidity. Interest-bearing debt of 8.3B yen represents minimal leverage with debt-to-equity ratio of 5.5%. Net defined benefit liability of 8.0B yen represents pension obligations.
Cash and deposits increased 1.6B yen YoY to 38.0B yen, supported by retained earnings growth of 11.6B yen reflecting profit accumulation. However, working capital deterioration absorbed significant cash, with work in process increasing substantially and trade receivables rising to 43.7B yen. Property, plant and equipment expanded 10.0B yen, indicating major capital investment in production capacity. Long-term borrowings increased 5.1B yen to 8.3B yen, likely financing the capital expenditure program. Trade payables of 10.3B yen provide 55 days of supplier credit. The interest coverage ratio of approximately 301x based on operating income to interest expense demonstrates negligible debt service burden. Investment securities holdings of 16.8B yen declined as evidenced by the 1.0B yen securities sale gain. Despite strong balance sheet liquidity with current ratio of 258.7%, the sharp deterioration in operating working capital (receivables collection and inventory management) suggests cash generation quality has weakened and requires operational improvement to restore efficient capital deployment.
Ordinary income of 23.7B yen versus operating income of 21.4B yen shows non-operating net contribution of approximately 2.3B yen, comprising equity method gains of 0.5B yen, interest and dividend income of 0.4B yen, and FX gains of 1.0B yen as primary components. Non-operating income represents 1.9% of revenue. Extraordinary income of 1.0B yen from securities sales represents a non-recurring item supporting reported profits. The presence of this one-time gain suggests core operating earnings were under greater pressure than headline net income indicates. The gap between operating and ordinary income is modest at 10.7%, suggesting limited reliance on financial engineering. However, the effective tax rate of 29.2% and tax burden coefficient of 0.708 are within normal ranges. Without operating cash flow data, earnings quality cannot be fully assessed through cash conversion metrics, but the severe working capital deterioration (507-day cash conversion cycle) strongly suggests earnings are not translating efficiently into cash. The buildup of work in process inventory (70.3% of total inventory) and extended receivables collection (123 days) indicate potential earnings quality concerns related to revenue recognition timing and inventory valuation risks.
Full-year forecast shows revenue of 181.0B yen and operating income of 24.0B yen. Q3 cumulative progress rates are 71.7% for revenue and 89.2% for operating income against full-year guidance. Revenue progress is 3.3 percentage points behind the standard 75% Q3 benchmark, while operating income progress is 14.2 percentage points ahead, indicating front-loaded profit recognition or conservative full-year guidance. The company maintained its forecast without revision this quarter. Full-year guidance implies Q4 revenue of 51.2B yen and operating income of 2.6B yen, representing significant sequential deceleration and suggesting anticipated seasonal weakness or conservative planning. The forecast assumes continued headwinds in international markets. Contract liabilities of 31.4B yen represent 17.3% of forecasted annual revenue, providing forward revenue visibility of approximately 2.1 months. No revision to dividend forecast of 53.00 yen per share, suggesting management confidence in cash generation despite operational challenges.
Annual dividend forecast of 53.00 yen per share represents a payout ratio of 31.2% based on forecasted EPS of 170.09 yen. This compares to prior year actual EPS of 390.00 yen, indicating significant expected earnings decline. The dividend policy appears sustainable given the conservative payout ratio and strong balance sheet position with 38.0B yen in cash against only 8.3B yen in interest-bearing debt. Total return ratio remains at dividend payout level of 31.2% as no share buyback activity is disclosed. The modest payout ratio provides substantial retained earnings for reinvestment, with retained earnings growing 11.6B yen to 97.7B yen. Treasury stock increased 0.8B yen, suggesting some repurchase activity, though specific buyback results are not separately quantified. The combination of conservative payout and strong liquidity positions dividends as sustainable even amid current profit pressure.
Working capital management deterioration poses the most critical operational risk, with cash conversion cycle of 507 days indicating 1.4 years to convert production inputs into cash collection. This ties up approximately 140.0B yen in operating working capital, constraining liquidity and return on invested capital. The 70.3% work in process ratio suggests production bottlenecks or demand forecasting mismatches that could lead to inventory writedowns or obsolescence charges. Geographic revenue concentration in China (25.9% of total) exposes results to regional economic volatility and geopolitical risks, evidenced by the 2.3B yen China revenue decline this period. Major capital expenditure program with property, plant and equipment increasing 41.5% creates execution risk and return on investment uncertainty, particularly given the 31.4B yen contract liability base provides only 2.1 months of revenue visibility to support capacity utilization.
[Industry Position] (Reference - Proprietary Analysis) The company's profitability metrics significantly exceed manufacturing industry medians. ROE of 11.7% substantially outperforms the industry median of 5.8%, ranking in the upper quartile. Operating margin of 16.5% considerably exceeds the industry median of 8.9%, demonstrating strong pricing power or cost advantages. Net profit margin of 13.5% more than doubles the industry median of 6.5%, indicating superior profitability. Financial health metrics are also favorable, with equity ratio of 63.9% aligned with industry median of 63.8%, reflecting typical sector capital structure. Current ratio of 258.7% substantially exceeds industry median of 2.87x (287%), indicating conservative liquidity management. However, operational efficiency shows notable weakness. Asset turnover of 0.554x is below the industry median of 0.56x, suggesting suboptimal capital deployment efficiency. Working capital metrics show severe deterioration relative to peers: receivables turnover of 123 days substantially exceeds industry median of 85 days, inventory turnover of 100 days is within industry median range of 112 days, but the cash conversion cycle metrics indicate overall working capital management significantly lags industry standards. Revenue declined 4.8% YoY versus industry median growth of 2.8%, positioning the company as an underperformer on top-line expansion. The combination of superior margins but inferior revenue growth and working capital efficiency suggests a company with strong competitive position but facing demand challenges and operational execution issues. (Industry: Manufacturing, 105 companies, Comparison: FY2025 Q3, Source: Proprietary analysis)
The company demonstrates exceptional profitability with operating margin of 16.5% and ROE of 11.7%, both substantially exceeding industry benchmarks, indicating structural competitive advantages and pricing power within its served markets. The Industrial Equipment segment margin of 44.0% represents world-class performance and serves as the primary profit engine, though at only 31.2% of revenue it presents concentration risk. However, severe working capital deterioration emerges as the critical concern, with 507-day cash conversion cycle and 70.3% work in process inventory ratio indicating fundamental operational inefficiencies that threaten cash generation despite reported profitability. The 41.5% increase in property, plant and equipment signals major capacity expansion, but the combination of contract liabilities providing only 2.1 months revenue visibility and declining sales (-4.8% YoY) raises questions about demand validation and return on invested capital for these investments. Geographic exposure to China (25.9% of revenue) contributed to current period weakness with 2.3B yen decline, suggesting structural market share or competitive challenges in this key region. The conservative financial profile with 63.9% equity ratio, minimal debt leverage, and 31.2% dividend payout ratio provides stability and downside protection, but capital allocation efficiency requires improvement as evidenced by below-industry asset turnover. The 89.2% operating income progress against 71.7% revenue progress toward full-year guidance suggests either conservative planning or anticipated sharp Q4 margin compression, warranting close monitoring of quarterly trends. Management's operational priorities should focus on working capital normalization and production efficiency restoration to convert strong reported margins into proportional cash generation and return value to the high capital base deployed.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.